Narges Ghandi

697 total citations
48 papers, 465 citations indexed

About

Narges Ghandi is a scholar working on Pathology and Forensic Medicine, Dermatology and Urology. According to data from OpenAlex, Narges Ghandi has authored 48 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pathology and Forensic Medicine, 21 papers in Dermatology and 20 papers in Urology. Recurrent topics in Narges Ghandi's work include Autoimmune Bullous Skin Diseases (26 papers), Hair Growth and Disorders (20 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (14 papers). Narges Ghandi is often cited by papers focused on Autoimmune Bullous Skin Diseases (26 papers), Hair Growth and Disorders (20 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (14 papers). Narges Ghandi collaborates with scholars based in Iran, United States and Australia. Narges Ghandi's co-authors include Maryam Daneshpazhooh, Robabeh Abedini, Maryam Nasimi, Maryam Ghiasi, Hamidreza Mahmoudi, Kamran Balighi, Cheyda Chams‐Davatchi, Amir Teimourpour, Zahra Akbari and Vahideh Lajevardi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American Academy of Dermatology and Phytotherapy Research.

In The Last Decade

Narges Ghandi

42 papers receiving 459 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Narges Ghandi Iran 13 197 197 147 105 105 48 465
Nikoo Mozafari Iran 11 125 0.6× 118 0.6× 49 0.3× 32 0.3× 56 0.5× 51 345
Rana Abdat United States 6 124 0.6× 139 0.7× 19 0.1× 80 0.8× 122 1.2× 9 376
Hassan Seirafi Iran 14 270 1.4× 359 1.8× 33 0.2× 139 1.3× 185 1.8× 23 693
Ali Balevi Türkiye 11 63 0.3× 181 0.9× 54 0.4× 23 0.2× 54 0.5× 33 314
Necmettin Kırtak Türkiye 12 81 0.4× 134 0.7× 22 0.1× 37 0.4× 108 1.0× 24 426
Ahmet Akar Türkiye 10 49 0.2× 144 0.7× 118 0.8× 12 0.1× 39 0.4× 18 349
Ding-Dar Lee Taiwan 9 108 0.5× 261 1.3× 157 1.1× 6 0.1× 59 0.6× 10 454
Wimolsiri Iamsumang Thailand 9 37 0.2× 160 0.8× 144 1.0× 21 0.2× 31 0.3× 21 294
Catherine Reid Australia 10 52 0.3× 232 1.2× 28 0.2× 16 0.2× 44 0.4× 15 353
Ryokichi Irisawa Japan 11 65 0.3× 140 0.7× 200 1.4× 18 0.2× 27 0.3× 30 326

Countries citing papers authored by Narges Ghandi

Since Specialization
Citations

This map shows the geographic impact of Narges Ghandi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Narges Ghandi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Narges Ghandi more than expected).

Fields of papers citing papers by Narges Ghandi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Narges Ghandi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Narges Ghandi. The network helps show where Narges Ghandi may publish in the future.

Co-authorship network of co-authors of Narges Ghandi

This figure shows the co-authorship network connecting the top 25 collaborators of Narges Ghandi. A scholar is included among the top collaborators of Narges Ghandi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Narges Ghandi. Narges Ghandi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ghandi, Narges, et al.. (2025). A Case of Severe Generalized Granuloma Annulare Responding Well to Tofacitinib. Case Reports in Dermatological Medicine. 2025(1). 3593724–3593724. 1 indexed citations
3.
Esmaeili, Farzad, et al.. (2024). Topical Immunotherapy with Diphenylcyclopropenone in Paediatric Patients with Alopecia Areata—A Retrospective Study of 97 Patients. SHILAP Revista de lepidopterología. 4(5). e441–e441. 1 indexed citations
4.
Aryanian, Zeinab, et al.. (2024). Generalized cutaneous talaromycosis (Penicilliosis) in an immunocompetent individual. JAAD Case Reports. 50. 97–101.
5.
Abedini, Robabeh, et al.. (2023). Is the severity of alopecia areata associated with arterial stiffness?. Journal of Research in Medical Sciences. 28(1). 80–80. 2 indexed citations
6.
Saedi, Babak, et al.. (2023). Hearing impairment in patients with alopecia areata. Indian Journal of Dermatology Venereology and Leprology. 90. 158–162. 1 indexed citations
7.
Bahri, Razman Arabzadeh, et al.. (2023). Efficacy and Safety of Platelet‐Rich Plasma Therapy in Alopecia Areata Patients: A Systematic Review. Dermatologic Therapy. 2023(1). 3 indexed citations
8.
Nasimi, Maryam, et al.. (2023). Effects of age and sex on the comorbidities of alopecia areata: A cross‐sectional hospital‐based study. Health Science Reports. 6(7). e1444–e1444. 3 indexed citations
9.
Shakiba, Saeed, et al.. (2021). Study of vitamin D deficiency in patients with alopecia areata attending a dermatology center in Iran. International Journal of Dermatology. 24(2). 97–101. 3 indexed citations
10.
Karbakhsh, Mojgan, et al.. (2021). Social participation in vitiligo patients and its association with quality of life. International Journal of Dermatology. 24(1). 6–10. 2 indexed citations
11.
Hatami, Parvaneh, et al.. (2021). A prospective comparative study of two regimens of diphenylcyclopropenone (DPCP) in the treatment of alopecia areata. International Immunopharmacology. 101(Pt B). 108186–108186. 12 indexed citations
12.
Nasimi, Maryam, et al.. (2020). Alopecia Areata-Quality of Life Index questionnaire (reliability and validity of the Persian version) in comparison to Dermatology Life Quality Index. International Journal of Trichology. 12(5). 227–227. 9 indexed citations
14.
Nasimi, Maryam, et al.. (2020). Utility of dermoscopic evaluation in predicting clinical response to diphencyprone in a cohort of patients with alopecia areata. International Journal of Trichology. 12(3). 107–107. 5 indexed citations
15.
Nasimi, Maryam, et al.. (2019). Efficacy and safety of anthralin in combination with diphenylcyclopropenone in the treatment of alopecia areata: a retrospective case series. Archives of Dermatological Research. 311(8). 607–613. 19 indexed citations
16.
Ghandi, Narges, et al.. (2016). Prolactin level changes in pemphigus vulgaris: A cohort study. 19(75).
17.
Mahmoudi, Hamidreza, Maryam Daneshpazhooh, Kamran Balighi, et al.. (2016). Neurological diseases and bullous pemphigoid: A case–control study in Iranian patients. Indian Journal of Dermatology Venereology and Leprology. 83(2). 195–195. 19 indexed citations
18.
Ghandi, Narges, et al.. (2015). Generalized eruptive histiocytosis: A case report. 18(1). 33–35.
19.
Ghandi, Narges, et al.. (2011). Comparison of the frequency of antinuclear antibodies in patients with pemphigus vulgaris and a control group. 2(2). 69–77.
20.
Valikhani, Mahin, Cheyda Chams‐Davatchi, Zahra Hallaji, et al.. (2008). Impact of smoking on pemphigus. International Journal of Dermatology. 47(6). 567–570. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026